Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasIntellectual disability psychiatry — neurodevelopmental dual diagnosis

Psych Vivas · Intellectual disability psychiatry — neurodevelopmental dual diagnosis

Autism and intellectual disability dual diagnosis — structured clinical viva

Fellowship viva on autism–ID dual diagnosis: criteria logic, AAC, epilepsy, PBS, and selective pharmacotherapy with population-specific evidence.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the dual-diagnosis / ID psychiatry registrar. A multidisciplinary meeting discusses a 12-year-old with moderate ID, suspected ASD, limited speech, weekly self-injury, and possible absence seizures. The paediatrician asks: (1) Can he have both ASD and ID? (2) How do you assess dual diagnosis and communication? (3) How does epilepsy change risk and workup? (4) What is the stepped plan for challenging behaviour, including when medicines are justified? Cover relative developmental rule, AAC, epilepsy gradient, PBS, RUPP/Owen dosing-monitoring, and Tyrer 2008.

Interpretation

Reveal interpretation

Can he have both? Yes. Dual coding of ASD and ID is allowed when both criteria are met. The hinge is that social communication is below that expected for developmental level, with RRBs and early onset — not IQ alone and not automatic dual labels.[1][2]

Assessment and communication. Developmental history, adaptive and cognitive assessment, multi-setting social-communication observation relative to mental age, RRB/sensory profile, collateral, structured tools as aids. Communication: audiology pathway, speech-language input, total communication, AAC immediately if speech is limited. Genetics after ASD diagnosis when indicated (microarray, fragile X).[1][2]

Epilepsy. Co-occurrence of epilepsy and autism is common and higher with ID. Possible absences need seizure history, neurology liaison, EEG when indicated; behaviour may be peri-ictal. Do not treat all stereotypy as seizure.[3]

Challenging behaviour stepped plan. Safety → medical pain screen → functional analysis/PBS → communication/AAC and environmental supports → treat epilepsy/mental health comorbidities → only then consider risperidone (RUPP: low start ~0.25–0.5 mg/day weight-based, metabolic/EPS/prolactin monitoring) or aripiprazole (Owen: often 2 mg start; metabolic/akathisia monitoring) for severe irritability. Name Tyrer 2008: antipsychotics not superior to placebo for aggression in adults with ID — population-specific prescribing.[4][5][6][7]

Name evidence. Hyman; Thurm; Lukmanji; McCracken RUPP; Owen; Tyrer; Emerson.[1][2][3][4][5][6][7]

Key points

Relative developmental rule

Social communication below developmental expectation is required for ASD when ID is present.

Epilepsy gradient

ID severity raises epilepsy concern in ASD — investigate red flags.

PBS before drugs; Tyrer vs RUPP

Formulate behaviour first; know which population your antipsychotic evidence comes from.
[2] [3] [6]

References

  1. [1]Hyman SL, Levy SE, Myers SM Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Pediatrics, 2020.PMID 31843864
  2. [2]Thurm A, Farmer C, Salzman E, Lord C, Bishop S State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder Front Psychiatry, 2019.PMID 31417436
  3. [3]Lukmanji S, et al. The co-occurrence of epilepsy and autism: A systematic review Epilepsy Behav, 2019.PMID 31398688
  4. [4]McCracken JT, et al. Risperidone in children with autism and serious behavioral problems N Engl J Med, 2002.PMID 12151468
  5. [5]Owen R, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics, 2009.PMID 19948625
  6. [6]Tyrer P, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability Lancet, 2008.PMID 18177776
  7. [7]Emerson E, et al. The prevalence of challenging behaviors: a total population study Res Dev Disabil, 2001.PMID 11263632